Patent ID: 8718995
Filing Date: 2014-05-06
Classification: A23L,G16C

Abstract:
1. A method for determining compatibility of bioactive agents for ingestion by a subject, comprising the steps of: (i) determining compatibility by and between components contained in a supplement formulation and generating a first compatibility factor based thereon; (ii) determining compatibility by and between said formulation components and a human body and generating a second compatibility factor based thereon; (iii) determining compatibility by and between said formulation components and a pharmacological agent and generating a third compatibility factor based thereon; and (iv) generating a bioactive agent profile based on said first, second and third compatibility factors that provides to the subject a compatible formulation of the bioactive agents; including at least one algorithm for determining said compatibility by and between said components contained in said supplement formulation; wherein the step of determining compatibility by and between said components contained in said supplement formulation includes the step of determining the components contained in at least two supplement formulations; wherein a first of said at least two supplement formulations does not include a combination of bioactive agents that hinder absorption of any of the bioactive agents present in said first supplement formulation, and wherein a second of said at least two supplement formulations does not include a combination of bioactive agents that hinder absorption of any of the bioactive agents present in said second supplement formulation; wherein said first supplement formulation is ingested by the subject during a first time period every 24 hours and wherein said second supplement formulation is ingested by the subject during a second time period every 24 hours, and wherein said second time period begins at least four hours after said first time period ends; and wherein ingesting of said first supplement formulation during said first time period and ingesting of said second supplement formulation during said second time period prevents any adverse interactions from occurring between any of the bioactive agents in said first supplement formulation and any of the bioactive agents in said second supplement formulation.